Sanuwave Health ROE 2010-2024 | SNWVD
Current and historical return on equity (ROE) values for Sanuwave Health (SNWVD) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Sanuwave Health ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2024-06-30 | $-0.00B | $-0.04B | 8.12% |
| 2024-03-31 | $-0.02B | $-0.05B | 33.03% |
| 2023-12-31 | $-0.03B | $-0.04B | 46.43% |
| 2023-09-30 | $-0.05B | $-0.07B | 90.09% |
| 2023-06-30 | $-0.03B | $-0.06B | 57.14% |
| 2023-03-31 | $-0.02B | $-0.05B | 44.44% |
| 2022-12-31 | $-0.01B | $-0.04B | 27.59% |
| 2022-09-30 | $-0.01B | $-0.03B | 36.36% |
| 2022-06-30 | $-0.02B | $-0.03B | 45.71% |
| 2022-03-31 | $-0.03B | $-0.04B | 82.44% |
| 2021-12-31 | $-0.03B | $-0.04B | 97.30% |
| 2021-09-30 | $-0.03B | $-0.03B | 139.53% |
| 2021-06-30 | $-0.04B | $-0.03B | 240.00% |
| 2021-03-31 | $-0.03B | $-0.02B | 247.27% |
| 2020-12-31 | $-0.03B | $-0.01B | 250.98% |
| 2020-09-30 | $-0.02B | $-0.01B | 195.74% |
| 2020-06-30 | $-0.01B | $-0.02B | 101.96% |
| 2020-03-31 | $-0.01B | $-0.01B | 92.31% |
| 2019-12-31 | $-0.01B | $-0.01B | 80.00% |
| 2019-09-30 | $-0.01B | $-0.01B | 66.67% |
| 2019-06-30 | $-0.01B | $-0.02B | 53.33% |
| 2019-03-31 | $-0.01B | $-0.02B | 54.24% |
| 2018-12-31 | $-0.01B | $-0.02B | 84.21% |
| 2018-09-30 | $-0.01B | $-0.01B | 100.00% |
| 2018-06-30 | $-0.01B | $-0.02B | 108.33% |
| 2018-03-31 | $-0.01B | $-0.01B | 107.32% |
| 2017-12-31 | $-0.01B | $-0.01B | 58.82% |
| 2017-09-30 | $-0.00B | $-0.01B | 51.61% |
| 2017-06-30 | $-0.00B | $-0.01B | 57.14% |
| 2017-03-31 | $-0.00B | $-0.01B | 61.54% |
| 2016-12-31 | $-0.01B | $-0.01B | 100.00% |
| 2016-09-30 | $-0.01B | $-0.01B | 86.96% |
| 2016-06-30 | $-0.01B | $-0.01B | 90.91% |
| 2016-03-31 | $-0.01B | $-0.01B | 120.00% |
| 2015-12-31 | $-0.01B | $-0.01B | 111.11% |
| 2015-09-30 | $-0.00B | $-0.01B | 114.29% |
| 2015-06-30 | $-0.00B | $-0.00B | 177.78% |
| 2015-03-31 | $-0.00B | $-0.00B | 400.00% |
| 2014-12-31 | $-0.01B | $-0.00B | -2400.00% |
| 2014-09-30 | $-0.01B | $0.00B | 933.33% |
| 2014-06-30 | $-0.01B | $0.00B | 444.44% |
| 2014-03-31 | $-0.01B | $0.00B | 163.64% |
| 2013-12-31 | $-0.01B | $-0.01B | 125.71% |
| 2013-09-30 | $-0.01B | $-0.01B | 133.33% |
| 2013-06-30 | $-0.01B | $-0.01B | 100.00% |
| 2013-03-31 | $-0.01B | $-0.01B | 128.57% |
| 2012-12-31 | $-0.01B | $-0.01B | 120.00% |
| 2012-09-30 | $-0.01B | $-0.01B | 160.00% |
| 2012-06-30 | $-0.01B | $-0.00B | 311.11% |
| 2012-03-31 | $-0.01B | $-0.00B | 1333.33% |
| 2011-12-31 | $-0.01B | $-0.00B | 444.44% |
| 2011-09-30 | $-0.02B | $0.00B | 333.33% |
| 2011-06-30 | $-0.02B | $0.00B | 206.45% |
| 2011-03-31 | $-0.02B | $-0.01B | 136.36% |
| 2010-12-31 | $-0.02B | $-0.01B | 148.84% |
| 2010-09-30 | $-0.01B | $-0.01B | 126.32% |
| 2010-06-30 | $-0.01B | $-0.01B | 165.52% |
| 2010-03-31 | $-0.01B | $-0.01B | 177.78% |
| 2009-12-31 | $-0.01B | $-0.01B | 280.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.062B | $0.020B |
| SANUWAVE Health, Inc. is engaged in the development and commercialization of non-invasive, biological response-activating devices for the repair and regeneration of tissue, musculoskeletal and vascular structures. The Company's product candidates include its proprietary PACE technology applicable in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions; and dermaPACE for treatment of the skin and subcutaneous soft tissue. The Company's products help in activating biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. SANUWAVE Health, Inc. is based in Alpharetta, USA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $198.731B | 25.27 |
| Stryker (SYK) | United States | $134.451B | 31.42 |
| Boston Scientific (BSX) | United States | $124.776B | 35.90 |
| Medtronic (MDT) | Ireland | $116.179B | 17.29 |
| EssilorLuxottica (ESLOY) | France | $108.009B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.167B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.588B | 32.83 |
| ResMed (RMD) | United States | $37.582B | 30.89 |
| Koninklijke Philips (PHG) | Netherlands | $29.768B | 22.62 |
| Terumo (TRUMY) | Japan | $28.517B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.844B | 13.12 |
| Baxter (BAX) | United States | $18.351B | 12.45 |
| Insulet (PODD) | United States | $16.381B | 68.92 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.403B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.925B | 29.57 |
| Demant (WILYY) | Denmark | $8.516B | 0.00 |
| BellRing Brands (BRBR) | United States | $8.334B | 35.24 |
| Lantheus Holdings (LNTH) | United States | $7.658B | 18.38 |
| ICU Medical (ICUI) | United States | $4.288B | 40.92 |
| Haemonetics (HAE) | United States | $3.867B | 19.13 |
| Prestige Consumer Healthcare (PBH) | United States | $3.620B | 18.03 |
| TG Therapeutics (TGTX) | United States | $3.617B | 38.29 |
| Perrigo (PRGO) | Ireland | $3.423B | 10.81 |
| Envista Holdings (NVST) | United States | $3.248B | 17.33 |
| Neogen (NEOG) | United States | $2.993B | 34.53 |
| GN Store Nord (GNNDY) | Denmark | $2.930B | 17.65 |
| QuidelOrtho (QDEL) | United States | $2.601B | 16.39 |
| Agios Pharmaceuticals (AGIO) | United States | $2.565B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.328B | 39.29 |
| Curaleaf Holdings (CURLF) | Canada | $2.216B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.924B | 51.28 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.771B | 0.00 |
| Warby Parker (WRBY) | United States | $1.723B | 0.00 |
| InMode (INMD) | Israel | $1.474B | 9.39 |
| AdaptHealth (AHCO) | United States | $1.432B | 10.34 |
| AtriCure (ATRC) | United States | $1.360B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.278B | 0.00 |
| Evolus (EOLS) | United States | $1.039B | 0.00 |
| Owens & Minor (OMI) | United States | $1.034B | 7.98 |
| BioLife Solutions (BLFS) | United States | $1.016B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.989B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.949B | 19.69 |
| PetIQ (PETQ) | United States | $0.926B | 23.47 |
| CeriBell (CBLL) | United States | $0.894B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.796B | 0.00 |
| National Vision Holdings (EYE) | United States | $0.770B | 24.48 |
| Surmodics (SRDX) | United States | $0.536B | 113.91 |
| VAREX IMAGING (VREX) | United States | $0.528B | 15.94 |
| Canopy Growth (CGC) | Canada | $0.511B | 0.00 |
| Valneva SE (VALN) | France | $0.483B | 0.00 |
| Quanterix (QTRX) | United States | $0.479B | 0.00 |
| ZimVie (ZIMV) | United States | $0.382B | 35.56 |
| Viemed Healthcare (VMD) | United States | $0.359B | 38.50 |
| Jin Medical (ZJYL) | China | $0.338B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.336B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.325B | 0.00 |
| Cerus (CERS) | United States | $0.309B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.301B | 7.75 |
| Zynex (ZYXI) | United States | $0.290B | 60.80 |
| Biote (BTMD) | United States | $0.278B | 12.82 |
| Sanara MedTech (SMTI) | United States | $0.277B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.276B | 0.00 |
| High Tide (HITI) | Canada | $0.243B | 100.67 |
| Omeros (OMER) | United States | $0.243B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.223B | 14.81 |
| MacroGenics (MGNX) | United States | $0.219B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.201B | 0.00 |
| Brainsway (BWAY) | Israel | $0.161B | 193.00 |
| FitLife Brands (FTLF) | United States | $0.146B | 19.70 |
| Veru (VERU) | United States | $0.122B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.119B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.117B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.116B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.104B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.096B | 23.65 |
| Fonar (FONR) | United States | $0.096B | 9.95 |
| Zevia PBC (ZVIA) | United States | $0.082B | 0.00 |
| InterCure (INCR) | Israel | $0.077B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.073B | 0.00 |
| Modular Medical (MODD) | United States | $0.072B | 0.00 |
| Safety Shot (SHOT) | United States | $0.065B | 0.00 |
| MariMed (MRMD) | United States | $0.063B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.057B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.049B | 0.00 |
| Exagen (XGN) | United States | $0.047B | 0.00 |
| Apyx Medical (APYX) | United States | $0.042B | 0.00 |
| ImmuCell (ICCC) | United States | $0.028B | 0.00 |
| Flora Growth (FLGC) | United States | $0.025B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.017B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Nephros (NEPH) | United States | $0.015B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Agape ATP (ATPC) | $0.008B | 0.00 | |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Senestech (SNES) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 18.47 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |